Pharma Mar | PHM - Ebitda

Aktienkurs
96.30
Täglich Wechseln
-1.30 -1.33%
Monatlich
-1.23%
Jährlich
22.68%
Q2 Prognose
93.78




Ebitda Veränderung Datum
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Almirall EUR 114.07M 60.37M 2025-12
Avita Medical AUD -9.69M 12.21M 2025-12
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Moderna USD -790M 582M 2025-12
Organon & Co USD 415M 32M 2026-03
Pharma Mar EUR 2.71M 42.25M 2026-03
Revvity USD 272.91M 24M 2026-03
Tectonic Therapeutic USD -21.18M 365K 2025-12
Viatris USD 1.05B 46.4M 2026-03
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12